Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
The U.S. CDC approves the Pfizer–BioNTech COVID-19 vaccine for children aged 5 and 11 years old. 2021-11-2
The first 30,000 doses of the Pfizer-BioNTech vaccine are sent from Spain to Andorra after both governments reached an agreement earlier today. 2021-01-19
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Chile begins its vaccination campaign against COVID-19 after the arrival of 10,000 doses of Pfizer-BioNTech vaccine to the country. 2020-12-24
The Ministry of Public Health approves the authorization of the Pfizer-BioNTech vaccine for emergency use in Qatar. 2020-12-20
Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021. 2020-12-14
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7
The United Kingdom approves the BNT162b2 vaccine made by Pfizer and BioNTech for widespread use, becoming the first country in the world to approve the vaccine. The government states that the vaccine will be rolled out early next week. 2020-12-2
The government announces that they have signed a deal with Pfizer and BioNTech to purchase 1.5 million vaccine doses for 750,000 people in the country. 2020-10-11